학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 755건 | 목록 1~20
Academic Journal
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China, 510080.; Dziadziuszko R; Department of Oncology & Radiotherapy and Early Phase Clinical Trials Centre, Medical University of Gdansk, Gdańsk, Poland, 80-214.; Ahn JS; Department of Hematology & Oncology, Samsung Medical Center, Seoul, South Korea, 06351.; Barlesi F; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France, 94805, Paris Saclay University, Faculty of Medicine, Kremlin-Bicêtre, France, 94270.; Nishio M; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 135-0063.; Lee DH; Asan Medical Center, Seoul, South Korea, 05505.; Lee JS; Seoul National University Bundang Hospital, Seongnam, South Korea, 13620.; Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China, 510080.; Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan, 104-0045.; Mao W; Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, China, 310022.; Hochmair M; Department of Respiratory & Critical Care Medicine, Karl-Landsteiner-Institute of Lung Research & Pulmonary Oncology, Clinic Floridsdorf, Vienna, Austria, 1210.; de Marinis F; Thoracic Oncology Division, European Institute of Oncology (IRCSS), Milano, Italy, 20141.; Migliorino MR; Pneumo-Oncology Unit, San Camillo Forlanini Hospital, Roma, Italy, 00152.; Bondarenko I; Oncology and Medical Radiology Department, Dnipropetrovsk Medical Academy, Dnipro, Ukraine, 49044.; Lu S; Department of Medical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 200030.; Wang Q; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China, 20003.; Lohmann TO; PD Oncology, F. Hoffmann-La Roche, Basel, Switzerland, 4070.; Xu T; Department of Clinical Science, Roche (China) Holding Ltd, Shanghai, China, 201203.; Cardona A; Data and Statistical Sciences, F. Hoffmann-La Roche, Basel, Switzerland, 4070.; Hiles L; PD Safety, F. Hoffmann-La Roche, Basel, Switzerland, 4070.; Noe J; Translational Medicine, F. Hoffmann-La Roche, Basel, Switzerland, 4070.; Solomon BJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia, 3000.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101665030 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2056-5623 (Print) Linking ISSN: 20565623 NLM ISO Abbreviation: Future Sci OA Subsets: PubMed not MEDLINE
Academic Journal
Huber, R M, Hansen, K H, Paz-Ares Rodríguez, L, West, H L, Reckamp, K L, Leighl, N B, Tiseo, M, Smit, E F, Kim, D-W, Gettinger, S N, Hochmair, M J, Kim, S-W, Langer, C J, Ahn, M-J, Kim, E S, Kerstein, D, Groen, H J M & Camidge, D R 2020, 'Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial', Journal of Thoracic Oncology, vol. 15, no. 3, pp. 404-415. https://doi.org/10.1016/j.jtho.2019.11.004
Huber, R M, Hansen, K H, Paz-Ares Rodríguez, L, West, H L, Reckamp, K L, Leighl, N B, Tiseo, M, Smit, E F, Kim, D W, Gettinger, S N, Hochmair, M J, Kim, S W, Langer, C J, Ahn, M J, Kim, E S, Kerstein, D, Groen, H J M & Camidge, D R 2020, ' Brigatinib in Crizotinib-Refractory ALK+ NSCLC : 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial ', Journal of Thoracic Oncology, vol. 15, no. 3, pp. 404-415 . https://doi.org/10.1016/j.jtho.2019.11.004
Academic Journal
Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Möller J; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany.; Christopoulos P; Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Wenzel C; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Rasokat A; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Wang XA; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Vathiotis I; Third Department of Internal Medicine, Sotiria Hospital, National, and Kapodistrian University of Athens, Athens, Greece.; König D; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Illini O; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria.; Grohé C; Department of Respiratory Diseases - ELK, Lindenberger Weg 27, 13125 Berlin, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Wiesweg M; West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Wesseler C; Department of Pneumology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, Germany.; Schubart C; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Pelusi N; Institute of Pathology, University Hospital, University of Bonn, Venusberg-Campus 1, Gebäude 62, 53127 Bonn, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Rohde G; Goethe University Frankfurt, University Hospital, Medical Clinic I, Department of Respiratory Medicine, Frankfurt/Main, Germany.; Overbeck TR; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen University, Göttingen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Kirfel J; Institute of Pathology, UKSH Campus Lübeck, University Hospital Schleswig-Holstein, Ratzenburger Allee 160, Haus V50, 23538 Lübeck, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Alt J; Department of Hematology and Medical Oncology, University Medical Center Mainz, Mainz, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Kauffmann-Guerrero D; Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Thoracic Oncology Center Munich, University Hospital, University of Munich (LMU), Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Griesinger F; Department of Hematology and Oncology, Pius Hospital, University Medicine Oldenburg, Oldenburg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Kulhavy J; Translational Oncology/Early Clinical Trial Unit (ECTU), Bavarian Cancer Research Center, National Center for Tumor Diseases, Comprehensive Cancer Center Mainfranken and University Hospital Würzburg, Würzburg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Klimova A; Core Unit for Data Management and Analytics, National Center for Tumor Diseases, Dresden, Germany.; Schütz M; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Aust DE; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Hochmair MJ; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria.; Rothschild SI; Cantonal Hospital Baden, Department Internal Medicine, Center of Oncology & Hematology, Baden, Switzerland.; Syrigos KN; Third Department of Internal Medicine, Sotiria Hospital, National, and Kapodistrian University of Athens, Athens, Greece.; Veluswamy R; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Michels S; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Stenzinger A; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.; Jöhrens K; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Department for Pathology, Klinikum Chemnitz gGmbH, Chemnitz, Germany.; Wermke M; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany. Electronic address: martin.wermke@ukdd.de.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Hochmair, M J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어